Loading

Saturday, August 11, 2012

Google Alert - asthma medications

News9 new results for asthma medications
 
Fighting fall allergies: The best treatments to feel better fast
Milwaukee Journal Sentinel
According to the American Academy of Allergy, Asthma and Immunology, from 2000 to 2005, the cost of treating allergic rhinitis nearly doubled from $6.1 billion to $11.2 billion. More than half of that was spent on prescription and over-the-counter ...
See all stories on this topic »
Asthma Drug Helps Kids Avoid Sleep Apnea Surgery?
WebMD
New research in the September 2012 issue of Pediatrics suggests an allergy and asthma drug -- montelukast (Singulair, which just went generic) -- may lessen symptoms in children with non-severe apnea and potentially allow them to skip the surgery.
See all stories on this topic »
Teva asthma, allergy drug approved by FDA
Jerusalem Post
Teva Pharmaceutical Industries Ltd.is one of ten companies to obtain US Food and Drug Administration (FDA) approval for a version of Merck's asthma and allergies drug Singulair in adults and children. Brand Singulair, made by Merck & Co., has $5 ...
See all stories on this topic »
New generic Singulair could save asthma sufferers big bucks
ConsumerReports.org
Montelukast, the generic name of the medication in Singulair, helps reduce asthma and allergy symptoms by blocking substances in the body called leukotrienes that can trigger inflammation and constrict airways. The most common side effects of the drug ...
See all stories on this topic »
Some asthma meds overprescribed for children
The Virtual Medical Centre
One type of medicine used to treat asthma is being overprescribed to children while other possible treatments are being ignored, according to an Australian respiratory medicine expert. Writing in the latest edition of Australian Prescriber, Professor ...
See all stories on this topic »

The Virtual Medical Centre
MURRIETA: Severe asthma is teen's motivation, not handicap
Press-Enterprise
He has undergone four surgeries, the most recent a year ago, and takes seven medications — sometimes more — daily to manage his asthma. Among Carey's daily routines is checking the air quality to make sure it is acceptable for him to breathe outdoors.
See all stories on this topic »

Press-Enterprise
United States : FDA grants approval to TEVA to market generic asthma treatment ...
Equities.com
Teva Pharmaceutical Industries Ltd. is one among ten firms to receive US Food and Drug Administration (FDA) approval for generic versions of asthma and allergies treatment Singulair in adults and children. Produced by Merck & Co., brand Singulair, has ...
See all stories on this topic »
Mylan Launches Generic Version of Singulair® Tablets and Singulair ...
Equities.com
7, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Montelukast ...
See all stories on this topic »
FDA Approves Generic Singulair
dailyRx
Montelukast is in a class of medications called leukotriene receptor antagonists. It works by blocking the action of leukotrienes, substances in the body that cause the symptoms of asthma and hayfever (allergic rhinitis). "For people who suffer from ...
See all stories on this topic »

Web2 new results for asthma medications
 
-> singulair asthma medication coupon - Cheap European Drugs.
singulair asthma medication coupon. By purchasing generic medications! singulair asthma medication coupon, Online Pharmacy UK! Online pharmacies ...
fcnit.com/?kopoilk=singulair-asthma-medication-coupon...
Asthma Inhaler Self Administration Form - Mondovi School District
AUTHORIZATION FOR SELF-ADMINISTRATION. OF INHALED ASTHMA MEDICATIONS. (To be renewed annually and/or with dosage/medication changes) ...
www.mondovi.k12.wi.us/.../Asthma%20inhaler%20self%20ad...


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

No comments:

Post a Comment